An open-label, randomized trial of the combination of IFN-κ plus TFF2 with standard care in the treatment of patients with moderate COVID-19
2020 · EClinicalMedicine · 31 citations
https://doi.org/10.1016/j.eclinm.2020.100547
S
Shimeng Bai
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
16
Papers
100
Citations
4
h-index
4
i10-index
Shimeng Bai is an academic researcher from Bengbu Medical College. The author has contributed to research in topics: HIV Research and Treatment & Bacteriophages and microbial interactions & Virology and Viral Diseases. The author has an h-index of 4, co-authored 14 publications.
ORCID: 0000-0003-4020-1934Papers by this author
worksInfluenza A Virus–Host Specificity: An Ongoing Cross-Talk Between Viral and Host Factors
2021 · Frontiers in Microbiology · 16 citations
https://doi.org/10.3389/fmicb.2021.777885
T = 4 Icosahedral HIV-1 Capsid As an Immunogenic Vector for HIV-1 V3 Loop Epitope Display
2018 · Viruses · 14 citations
https://doi.org/10.3390/v10120667
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat